UBS cuts Qiagen price target, keeps rating neutral
UBS cut its Qiagen price target to $47.00 per share from $52.00 while maintaining a neutral rating, according to TradingView News via Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.